Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
- PMID: 31021391
- DOI: 10.1001/jamaoncol.2019.0641
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
Comment in
-
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B-in Reply.JAMA Oncol. 2019 Jun 1;5(6):916-917. doi: 10.1001/jamaoncol.2019.0650. JAMA Oncol. 2019. PMID: 31021372 No abstract available.
Comment on
-
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.JAMA Oncol. 2019 Jan 1;5(1):30-36. doi: 10.1001/jamaoncol.2018.4070. JAMA Oncol. 2019. PMID: 30267080 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
